Technical Analysis for NOVN - Novan, Inc.

Grade Last Price % Change Price Change
grade A 2.25 1.81% 0.04
NOVN closed up 1.81 percent on Friday, May 24, 2019, on 48 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Earnings due: May 28

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical NOVN trend table...

Date Alert Name Type % Chg
Boomer Buy Setup Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Parabolic Rise Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Jack-in-the-Box Bullish Bullish Swing Setup 1.81%
Calm After Storm Range Contraction 1.81%

Older signals for NOVN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Novan, Inc. is a late-stage pharmaceutical company. The Company is engaged in the development and commercialization of therapies using its nitric oxide platform. The Company develops product candidates using its Nitricil technology, which enables the Company to engineer tunable new chemical entities (NCEs). The Company's formulation science enables it to further tune the release of nitric oxide when applied to the skin by using the combinations of inactive ingredients. It is developing SB204 for the treatment of acne vulgaris in Phase III. The Company is developing its product candidate, SB206, for the treatment of external genital and perianal warts in Phase II. It is developing SB208, an investigational topical anti-fungal for the treatment of fungal infections of the skin and nails. It is developing SB204 for the treatment of inflammatory skin diseases. Its pipeline also includes SB414, a topical cream product candidate.
Medical Specialties Organ Systems Infectious Diseases Acne Product Candidates Acne Vulgaris Cutaneous Conditions Fungal Infections Inflammatory Skin Diseases Treatment Of Inflammatory Skin Diseases Wart
Is NOVN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 3.25
52 Week Low 0.65
Average Volume 549,637
200-Day Moving Average 1.7637
50-Day Moving Average 1.1942
20-Day Moving Average 1.4766
10-Day Moving Average 1.772
Average True Range 0.2435
ADX 47.08
+DI 39.3714
-DI 6.7287
Chandelier Exit (Long, 3 ATRs ) 1.7195
Chandelier Exit (Short, 3 ATRs ) 1.3905
Upper Bollinger Band 2.298
Lower Bollinger Band 0.6552
Percent B (%b) 0.97
BandWidth 111.255587
MACD Line 0.2949
MACD Signal Line 0.1915
MACD Histogram 0.1033
Fundamentals Value
Market Cap 35.96 Million
Num Shares 16 Million
EPS -4.08
Price-to-Earnings (P/E) Ratio -0.55
Price-to-Sales 129.29
Price-to-Book 8.46
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.48
Resistance 3 (R3) 2.47 2.38 2.44
Resistance 2 (R2) 2.38 2.33 2.39 2.42
Resistance 1 (R1) 2.32 2.29 2.33 2.33 2.41
Pivot Point 2.23 2.23 2.24 2.24 2.23
Support 1 (S1) 2.17 2.18 2.18 2.18 2.09
Support 2 (S2) 2.08 2.14 2.09 2.08
Support 3 (S3) 2.02 2.08 2.06
Support 4 (S4) 2.03